Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep 18;20(18):4614.
doi: 10.3390/ijms20184614.

Reparative and Regenerative Effects of Mesenchymal Stromal Cells-Promising Potential for Kidney Transplantation?

Affiliations
Review

Reparative and Regenerative Effects of Mesenchymal Stromal Cells-Promising Potential for Kidney Transplantation?

Merel Pool et al. Int J Mol Sci. .

Abstract

Mesenchymal stromal cells (MSCs) possess reparative, regenerative and immunomodulatory properties. The current literature suggests that MSCs could improve kidney transplant outcome via immunomodulation. In many clinical domains, research has also focussed on the regenerative and reparative effects of therapies with MSCs. However, in the field of transplantation, data on this subject remain scarce. This review provides an overview of what is known about the regenerative and reparative effects of MSCs in various fields ranging from wound care to fracture healing and also examines the potential of these promising MSC properties to improve the outcome of kidney transplantations.

Keywords: kidney transplantation; mesenchymal stromal cells; regeneration.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Gao F., Chiu S.M., Motan D.A.L., Zhang Z., Chen L., Ji H.-L., Tse H.-F., Fu Q.-L., Lian Q. Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. 2016;7:e2062. doi: 10.1038/cddis.2015.327. - DOI - PMC - PubMed
    1. Eurotransplant . Annual Report 2017. Eurotransplant; Leiden, The Netherlands: 2017.
    1. Moers C., Leuvenink H.G.D., Ploeg R.J. Donation after cardiac death: Evaluation of revisiting an important donor source. Nephrol. Dial. Transpl. 2010;25:666–673. doi: 10.1093/ndt/gfp717. - DOI - PubMed
    1. Kern S., Eichler H., Stoeve J., Klüter H., Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24:1294–1301. doi: 10.1634/stemcells.2005-0342. - DOI - PubMed
    1. De Vries D.K., Schaapherder A.F.M., Reinders M.E.J. Mesenchymal stromal cells in renal ischemia/reperfusion injury. Front. Immunol. 2012;3:162. doi: 10.3389/fimmu.2012.00162. - DOI - PMC - PubMed